Background: Two third of the thirty-seven million people living with HIV/AIDS (PLWHA) globally live in Africa. With the advent of antiretroviral drugs, African PLWHA are living longer and are at increased risk of cardiovascular diseases including high blood pressure (HBP). In this preliminary study, we assessed how often blood pressure (BP) was measured and recorded and the prevalence of HBP in PLWHA followed at three hospitals in Cameroon.Methods: We retrospectively analysed the blood pressure measurement frequency and data of patients enrolled in the HIV care at the Limbe Regional hospital, Bamenda Regional hospital and the Jamot hospital in Yaounde from 2014 to 2017. Files of all PLWHA aged ≥21years were reviewed. Sociodemographic, labor...
BACKGROUND:Guidelines recommend integrating hypertension screening for HIV-infected adults, but bloo...
Purpose: Elevated blood pressure is a well‐documented risk factor for cardiovascular disease and mor...
Thesis (Master's)--University of Washington, 2016-06Background: As treatment innovations increase th...
BACKGROUND: Antiretroviral therapy (ART) success has led people to live longer with HIV/AIDS (PLWH) ...
INTRODUCTION : the introduction of highly active antiretroviral therapy (HAART) in the treatment of ...
BackgroundNon-communicable diseases, including hypertension (HTN), are increasingly recognized as im...
BackgroundHypertension is among the most commonly diagnosed non-communicable diseases in Africa, and...
BACKGROUND: High prevalence of HIV and hypertension in sub-Saharan Africa puts adults living with HI...
International audienceAbstract Currently, the life expectancy of people living with the human immuno...
The prevalence of high blood pressure (HBP) and hypertension (HTN), awareness of the diagnoses, and ...
BACKGROUND: We aimed to assess the prevalence of hypertension in an unselected human immunodefici...
Background: Over the past three decades, the prevalence of hypertension has increased in sub-Saharan...
Background. The dual burden of cardiovascular diseases and Human Immunodeficiency Virus (HIV) in sub...
BACKGROUND:One of the key risk factors for cardiovascular disease is hypertension. Hypertension, whi...
BACKGROUND:Antiretroviral therapy scale-up in Sub-Saharan Africa has created a growing, aging HIV-po...
BACKGROUND:Guidelines recommend integrating hypertension screening for HIV-infected adults, but bloo...
Purpose: Elevated blood pressure is a well‐documented risk factor for cardiovascular disease and mor...
Thesis (Master's)--University of Washington, 2016-06Background: As treatment innovations increase th...
BACKGROUND: Antiretroviral therapy (ART) success has led people to live longer with HIV/AIDS (PLWH) ...
INTRODUCTION : the introduction of highly active antiretroviral therapy (HAART) in the treatment of ...
BackgroundNon-communicable diseases, including hypertension (HTN), are increasingly recognized as im...
BackgroundHypertension is among the most commonly diagnosed non-communicable diseases in Africa, and...
BACKGROUND: High prevalence of HIV and hypertension in sub-Saharan Africa puts adults living with HI...
International audienceAbstract Currently, the life expectancy of people living with the human immuno...
The prevalence of high blood pressure (HBP) and hypertension (HTN), awareness of the diagnoses, and ...
BACKGROUND: We aimed to assess the prevalence of hypertension in an unselected human immunodefici...
Background: Over the past three decades, the prevalence of hypertension has increased in sub-Saharan...
Background. The dual burden of cardiovascular diseases and Human Immunodeficiency Virus (HIV) in sub...
BACKGROUND:One of the key risk factors for cardiovascular disease is hypertension. Hypertension, whi...
BACKGROUND:Antiretroviral therapy scale-up in Sub-Saharan Africa has created a growing, aging HIV-po...
BACKGROUND:Guidelines recommend integrating hypertension screening for HIV-infected adults, but bloo...
Purpose: Elevated blood pressure is a well‐documented risk factor for cardiovascular disease and mor...
Thesis (Master's)--University of Washington, 2016-06Background: As treatment innovations increase th...